12:00 AM
Dec 24, 2012
 |  BC Week In Review  |  Company News  |  Other News

Orion, Mylan, Novartis neurology news

The companies settled a January 2011 suit filed in the U.S. District Court for the District of Delaware claiming Mylan's ANDA for a generic version of Parkinson's drug (PD) Comtan...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >